Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA

(2014) Lisa Villabona et al.   MODERN PATHOLOGY

IL-27 Driven Upregulation of Surface HLA-E Expression on Monocytes Inhibits IFN-γRelease by Autologous NK Cells

(2014) Fabio Morandi et al.   Journal of Immunology Research

The Dual Role of HLA-G in Cancer

(2014) Nathalie Rouas-Freiss et al.   Journal of Immunology Research

HLA-dependent tumour development: a role for tumour associate macrophages?

(2013) Maddalena Marchesi et al.   Journal of Translational Medicine

Role of non-classical MHC class I molecules in cancer immunosuppression

(2013) Grazyna Kochan et al.   OncoImmunology

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer

(2012) Emilia Andersson et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The Dendritic Cell-Regulatory T Lymphocyte Crosstalk Contributes to Tumor-Induced Tolerance

(2011) Nona Janikashvili et al.   Clinical & Developmental Immunology

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

(2011) M. Gooden et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of Gene Methylation in Antitumor Immune Response: Implication for Tumor Progression

(2011) Alfonso Serrano et al.   Cancers

The Emerging Role of HLA-E-Restricted CD8+T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors

(2010) Gabriella Pietra et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma

(2009) Hildur Helgadottir et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Human leukocyte antigen–G is expressed in advanced-stage ovarian carcinoma of high-grade histology

(2009) Catherine Menier et al.   HUMAN IMMUNOLOGY

Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4

(2009) J. McCormick et al.   HUMAN REPRODUCTION

Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma

(2009) A. Lin et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Does our Current Understanding of Immune Tolerance, Autoimmunity, and Immunosuppressive Mechanisms Facilitate the Design of Efficient Cancer Vaccines?

(2009) M. Sioud   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

(2008) E. D. Carosella et al.   BLOOD

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

(2008) Barbara Seliger   CANCER IMMUNOLOGY IMMUNOTHERAPY

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

(2008) L. Y. Han et al.   CLINICAL CANCER RESEARCH

Subtle Changes in Peptide Conformation Profoundly Affect Recognition of the Non-Classical MHC Class I Molecule HLA-E by the CD94–NKG2 Natural Killer Cell Receptors

(2008) Hilary L. Hoare et al.   JOURNAL OF MOLECULAR BIOLOGY

Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands

(2008) M. Campoli et al.   TISSUE ANTIGENS